OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
J Venom Res
Open-access
Aptamers
Open-access
Aptamers 2019
03-04 April 2019, Oxford
Submit a manuscript

Blog Full Right Sidebar

With Frame
ATDBio was established to provide high quality oligonucleotides to scientists around the world. ATDBio oligonucleotides are used successfully in academic and commercial research in the fields of genetics, genomics, molecular biology, biochemistry, biotechnology and nanotechnology. We supply a wide range of custom-made unmodified and chemically modified oligonucleotides for small and large scale applications. ATDBio specialises in highly modified oligonucleotides. Each oligonucleotide we make is unique, and we...
Read More
RIBOMIC Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies called the RiboART System. RIBOMIC has been promoting the pharmaceutical discovery program in collaboration with Otsuka Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., The University of Tokyo, and some other academic partners. Especially in April 2014, RIBOMIC entered into...
Read More
Aptamer Solutions Ltd: Continued success and growth has enabled Aptamer Group to restructure its Scientific Operations team. Increasing interest in the development of aptamers against small molecule targets has led to the formation of a dedicated scientific team. This is in addition to the existing team focused on aptamer generation against larger targets (proteins, viruses, cells etc). Aptamer Group has developed a unique displacement method...
Read More
PROTOCOL/METHOD ISSN: 2514-3247 Aptamers (2018), Vol 2, in press Published online: 12 June 2018 Full Text Access  Sladjana Slavkovic and Philip E. Johnson* Department of Chemistry and Centre for Research on Biomolecular Interactions, York University, Toronto, Ontario, Canada, M2R 1A1 *Correspondence to: Philip Johnson, Email: pjohnson@yorku.ca, Tel: 1 416 736 2100 x33119 Received: 31 January 2018 | Revised: 09 June 2018 | Accepted: 11 June 2018...
Read More
We are delighted to announce that Professor Günter Mayer will chair Aptamers 2019.  Professor Mayer is the Professor of Chemical Biology at Life and Medical Sciences Institute (LIMES), Bonn University, Germany, and heads an international team of researchers investigating the use of aptamer technology in understanding biological phenomena and developing nucleic acids as drugs or drug targets in novel diagnostic and therapeutic applications. Further information about his...
Read More
1 2 3 4 37

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Recent News

Professor Larry Gold to Deliver a Keynote Address at Aptamers 2020
August 1, 2019
Dr Nebojsa Janjic to Chair Aptamers 2020
July 21, 2019
Proposals to Chair Aptamers 2020 invited
May 20, 2019

Recent Cases